You’ve heard all about CBD in recent years. Starting as a fringe supplement everyone confused with weed, the international CBD market has become legitimised to the extent that high-CBD, low-THC cannabis flower is now as commonplace as CBD tinctures were five years ago.
Since it’s such an interesting topic, lots of people keep track of the latest developments in the CBD industry. Hardly anybody is ready, however, for what is coming next in the world of cannabis.
For decades, it was taken for a fact that cannabinoids couldn’t be synthesised. They’re too unstable, all the major pharmaceutical manufacturers told us. The best we could do was to synthesise THC, CBD, or other cannabinoids from Cannabis sativa and repackage them as pharmaceutical drugs.
All the while, a handful of researchers continued to dedicate their time to what many considered to be a foolish, desperate errand. Certain terpenes found in cannabis, they protested, closely resemble cannabinoids to the extent that they could potentially be converted.
The process of synthesising cannabinoids from terpenes had already been proven possible, but the costs were considered exorbitant. At the time, it was only possible to reconstruct individual terpenes into cannabinoids at a cost many times greater than cannabis extraction. That remained the state of the industry until the advent of Cyclic Terpene Assembly (CTA).
CTA has turned what many considered a pipe dream into a full-fledged reality. Instead of deriving CBD from hemp, which is an ultimately unreliable resource, this method takes discarded citrus peels and transforms them into pure CBD. Let us explain.
Have you ever noticed the powerful fragrance that emits from citrus fruits when you peel them? Citrus peels contain a terpene called limonene, which is also found in most strains of cannabis.
Terpenes, flavonoids, and cannabinoids all belong to a single wider category of plant substances called aromatic compounds. Most aromatic compounds share a similar structure, but limonene and cannabidiol (CBD) are nearly identical. They have similar boiling point, chemical bonds, and other overlapping attributes that have long made limonene a subject of keen study among cannabinoid scientists.
While you might not have known about it, pharmaceutical companies have been treating the advent of non-hemp cannabinoids as a done deal for decades. After the disappointments of Marinol, Sativex, and Epidiolex, each of which consist of isolated Cannabis sativa compounds, big business is clearly ready for a different approach.
The only catch is that they all expected synthesised cannabinoids to be at least five years away from mass-market production. We beat them to the punch, and CPatch CBX is proof that the non-hemp CBD revolution has arrived well ahead of schedule.
Offers repeatable results
Varies from batch to batch
Is 99%-pure and reconstructed from terpenes
Contains agricultural toxins and industry byproducts
Never contacts THC molecules
May contain trace amounts of THC
Has a source material that can easily be made into other cannabinoids
Requires lengthy breeding to produce new cannabinoids
Offers pharmaceutical-level performance metrics that please investors
Supports a volatile industry that resembles prior economic bubbles
You might be wondering why it’s important to move away from hemp as our global source of CBD in the first place. Here are three big reasons:
Hemp is an incredibly complex plant. Each phenotype expresses different oils, and it’s highly probable that the exact ratio of terpenes, flavonoids, and cannabinoids in cannabis alters its effects.
While this complexity is great to admire from afar, many CBD users want to have the same experience every time. The widely varying effects among cannabis phenotypes are, therefore, undesirable for investors and consumers alike.
What do all successful drugs, supplements, and over-the-counter (OTC) substances have in common? They offer reliable, repeatable results that consumers can count on time and again. If a popular medication had different effects every time you used it, you would have no choice but to view it negatively.
The only way to free CBD from its stigma as a fringe product is to embrace synthesised cannabinoids. Deriving cannabinoids from sources other than hemp is preferable for real-world reasons, but even based on optics alone, making the switch would only be natural.Would you rather use a substance that’s associated with unsustainable farming practices and illegal drugs or a different version of the same substance that has all the mainstream, scientific appeal of mass-produced OTC medications? It’s okay if you don’t feel safe using CBD from hemp—we wouldn’t either.
Like all cultivated plants, hemp was originally wild, and in its natural environment, Cannabis sativa seeks the light and sucks up lots of nutrients throughout its life cycle to produce large flowers called colas. Along with the vast quantities of nutrients that accompany water as it moves through growing cannabis plants, environmental toxins can slip in and contaminate hemp crops.
Hemp absorbs nutrients at such a rapid rate that it’s considered a bioaccumulator, which means that it’s a biological entity that almost seems designed to attract toxins. This plant is so great at filling itself with toxic substances that it was even planted at the site of the Chernobyl nuclear meltdown to suck up radiation.
Most hemp farmers use sustainable cultivation practices—try saying that sentence with a straight face. Hemp is a booming industry, and businesses in the agricultural sector will use any lifelines they have in an uncertain economy. There’s currently a huge push to produce hemp for CBD as cheaply and quickly as possible, which only magnifies the inherent bioaccumulant dangers of this plant.
Around 100 years ago, Aspirin rapidly became a popular panacea sold on drugstore shelves nationwide. The active ingredient in Aspirin is a synthesised form of salicin, which is found in willow tree bark.
By now, the international popularity of Aspirin and its related class of drugs has pushed production demand far beyond original expectations. If drug manufacturers had continued using willow trees to produce salicin just as healers before them had done for centuries, it’s possible that they would have needed to plant the whole Earth with willow trees just to keep up with demand.
Synthesis of drugs and supplements always leads to greater reliability, purity, and, ultimately, sustainability via increased efficiency. Instead of wasting millions of acres of arable land and billions of gallons of water on willow-tree Aspirin farms, we embraced the miracles of modern science to the entire world’s benefit. It’s time we learned from the lessons of history and forged a new, synthesised path forward for cannabinoids.
Let’s dive into the details surrounding Cyclic Terpene Assembly, the high-tech process behind non-hemp cannabinoids:
There are no solvents involved, and the only factors that go into CTA are cannabinoids and physics. We won’t get into all the finer details, but suffice to say that Cyclic Terpene Assembly adjusts limonene terpenes at the molecular level using nothing more than kinetic force. That means no ethanol, CO2, or other residue in your CBD—nothing but pure cannabidiol reconstructed from orange peels.
By changing just a few molecular bonds, it’s possible to transform limonene and other terpenes into a variety of cannabinoids. This much has been known for years, but with CTA, it’s finally possible to reconstruct terpenes into cannabinoids on a mass scale using nothing more than kinetic-based synthesis processes. The end result is a highly valuable substance derived from a citrus industry byproduct that would otherwise have been wasted.
CTA produces the same end result every single time—99.9%-pure CBD isolate with no traces of cannabis compounds other than cannabidiol. Remember that citrus-derived CBD is not related to hemp in any way, so it cannot contain any THC or other undesirable substances that might be present in hemp-derived CBD.
No. CPatch CBX is first-to-market in the UK and EU. As the synthesised cannabinoid industry evolves, you’ll witness our product line spreading into every category traditionally dominated by hemp CBD. Cannabinoids derived from hemp are less repeatable, messier, and costlier, and we think you’ll find CPatch CBX to be more effective than any CBD product you’ve ever tried.
We post CPatch CBX patches everywhere in the UK, Ireland, and EU. Recent legislative changes at home and in America have opened up the international CBD market significantly.
To make the right choices, it’s still important to read up on local laws and regulations. Always remember, however, that the international consensus on cannabis is swinging rapidly toward mainstream acceptance, which means that legal concerns over non-intoxicating cannabinoids like CBD are largely behind us. Contact us for information on our shipping policies to your area or any other questions.
Non-hemp CBD is a refreshing alternative to Cannabis sativa and its inherent problems. Over the next few years, synthesised forms of cannabinoids will become just as common as their cannabis-derived counterparts.
Cannabis flower will likely remain just as popular as it has been for thousands of years. For pills, tinctures, sprays, and topical products, however, the world will begin turning to non-hemp cannabinoids first since they’re more reliable and pure.
CPatch CBX is the European market’s first foray into this new saga of CBD history. None of us are prepared for the unique challenges that synthesised cannabinoids will pose to the existing cannabis market, but one thing is for sure—we can’t resist change for the better.
If it’s true that synthesised cannabinoids are purer and more reliable than cannabinoids from hemp, it’s our responsibility to help products like CPatch CBX reach their rightful place in the market. Let’s learn some more about our incredible flagship product and answer any lingering questions you might have:
Yes, citrus-derived CBD is bioidentical with cannabidiol derived from hemp, which means these two substances share the exact same molecular structure. What’s missing are the agricultural contaminants and trace cannabinoids that are inevitably present in even the best hemp-derived CBD.
The CBD in CPatch CBX is not synthetic. Let us explain.
Since it comes from limonene, a constituent of citrus peels, our CBD is not derived from inert materials or synthesised chemically. The process of turning limonene into cannabidiol with CTA is, however, technically a form of synthesis if you want to use the correct scientific verbiage.
Over the years, people have gotten the wrong idea about cannabinoid synthesis due to fake marijuana drugs like K2 and Spice. While many in the media and elsewhere get this fine point wrong, these drugs don’t actually contain “synthetic cannabinoids.”
Instead, they are pharmaceutical chemicals designed to loosely mimic the effects of THC. Drugs like Spice and K2 are not molecularly identical (bioidentical) to any cannabinoids, so they are in no way similar to citrus-derived CBD. In time, the sad history of these illegal drugs will fade away, but CTA-reconstructed cannabinoids will only become more popular.
The world of cannabis science is always evolving, which keeps it fascinating. Just two decades ago, marijuana breeders thought it was just a pipe dream to breed strains with high CBD and low THC. Now, the international CBD industry spans every continent save Antarctica, and governments around the world are being forced to contend with an organised phenomenon that threatens to rewrite more than half a century of drug laws.
Given the unexpected, overwhelming popularity of CBD, it was only a matter of time before someone cracked the cannabinoid synthesis code. We’re just lucky that it was an independent producer, not an interlocked pharmaceutical megalith, that developed non-hemp CBD first. Otherwise, you wouldn’t have the unprecedented access to citrus-derived CBD that’s laid before you today.
You don’t have to settle for hemp anymore just to use CBD. Though it’s non-intoxicating, hemp is still associated with marijuana, and let’s be honest—it’s going to take a long time to fully erase that stigma. The CBD in CPatch CBX is produced in a state-of-the-art, certified lab by PhD chemists with backgrounds in the pharmaceutical industry.
We aren’t hemp growers, and what we’re offering is the farthest thing from Cannabis sativa and all its associated problems. CPatch CBX is 100% THC-free, and it doesn’t contain any other cannabinoids aside from CBD either. It’s repeatable and pure, meaning you’ll get the same results every time.
CPatch CBX is everything you ever wanted from CBD but you were too afraid to ask. Feel the revolution with CPatch CBX today.